Freeline Therapeutics Holdings PLC (FRLN) is up 9.03% Wednesday In Premarket Trading

Wednesday, October 18, 2023 07:15 AM | InvestorsObserver Analysts

Mentioned in this article

Freeline Therapeutics Holdings PLC (FRLN) is up 9.03% Wednesday In Premarket Trading

Freeline Therapeutics Holdings PLC (FRLN) has gained Wednesday morning, with the stock climbing 9.03% in pre-market trading to 4.71. FRLN's short-term technical score of 35 indicates that the stock has traded less bullishly over the last month than 65% of stocks on the market. In the Biotechnology industry, which ranks 135 out of 146 industries, FRLN ranks higher than 57% of stocks. Freeline Therapeutics Holdings PLC has risen 15.20% over the past month, closing at $3.85 on September 20. During this period of time, the stock fell as low as $2.85 and as high as $5.30. FRLN has an average analyst recommendation of Strong Buy. The company has an average price target of $9.00.

FRLN has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on FRLN!

See Full FRLN Report

Freeline Therapeutics Holdings PLC has a Long-Term Technical rank of 77. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 23% of the market scoring higher. In the Biotechnology industry which is number 138 by this metric, FRLN ranks better than 138% of stocks.

Important Dates for Investors in FRLN:

-Freeline Therapeutics Holdings PLC is set to release earnings on 2023-11-21. Over the last 12 months, the company has reported EPS of $-3.93. -We do not have a set dividend date for Freeline Therapeutics Holdings PLC at this time. Click Here To Get The Full Report on Freeline Therapeutics Holdings PLC (FRLN)